Seventure

Clinical Microbiomics adds long-read DNA&RNA sequencing with DNASense acquisition
1 March 2024

Clinical Microbiomics adds long-read DNA&RNA sequencing with DNASense acquisition

Danish contract research organisation Clinical Microbiomics today reveals the acquisition of DNASense, specializing in long-read DNA and RNA sequencing technologies and...

Read more
Citryll announces the appointment of Maarten Kraan as Chief Medical Officer
13 February 2024

Citryll announces the appointment of Maarten Kraan as Chief Medical Officer

Citryll, a clinical-stage biotech company developing first-in-class therapeutics to treat immune-mediated inflammatory diseases, today announced the appointment of Maarten...

Read the press release
STARFISH Bioscience Raises €900,000 From Seventure Partners To Regenerate Soil Microbiomes By Developing The Next Generation Of Microbial Biostimulants For Sustainable Agriculture
6 February 2024

STARFISH Bioscience Raises €900,000 From Seventure Partners To Regenerate Soil Microbiomes By Developing The Next Generation Of Microbial Biostimulants For Sustainable Agriculture

Starfish Bioscience today announced that it has raised €900,000 from Seventure Partners, the world's leading investor in the microbiome field through its Health for Life...

Read the press release
SumUp taps €285M more in growth funding to weather the fintech storm
11 December 2023

SumUp taps €285M more in growth funding to weather the fintech storm

SumUp — the fintech that provides payments and related services to some 4 million small businesses in Europe, the Americas and Australia — has picked up some growth funding...

Read more
MaaT Pharma to Present Preclinical Data at SITC on MaaT034, an Artificial Intelligence-Generated Product Aimed at Improving Patients’ Responses to Immunotherapies
31 October 2023

MaaT Pharma to Present Preclinical Data at SITC on MaaT034, an Artificial Intelligence-Generated Product Aimed at Improving Patients’ Responses to Immunotherapies

MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotech company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to...

Read more
Enterome Selected to The Leukemia & Lymphoma Society’s Therapy Acceleration Program
30 October 2023

Enterome Selected to The Leukemia & Lymphoma Society’s Therapy Acceleration Program

Enterome, a clinical-stage company developing first-in-class immunomodulatory drugs for solid and liquid malignancies and inflammatory diseases based on its unique Mimicry...

Read more
MaaT Pharma Announces Positive Outcome Following DSMB Review Reinforcing Confidence in Phase 3 On-Going Trial in Acute Graft-versus-Host Disease with MaaT013
26 October 2023

MaaT Pharma Announces Positive Outcome Following DSMB Review Reinforcing Confidence in Phase 3 On-Going Trial in Acute Graft-versus-Host Disease with MaaT013

MaaT Pharma today announced that the DSMB unanimously recommended that the open-label, single arm pivotal Phase 3 clinical trial evaluating MaaT013 in acute Graft-versus-Host...

Read more
CorWave announces the grand opening of its manufacturing facility on the banks of the Seine, next to Paris
9 October 2023

CorWave announces the grand opening of its manufacturing facility on the banks of the Seine, next to Paris

A French company that develops and manufactures innovative cardiac assist devices, held the grand opening of its new facility on the banks of the Seine in Clichy, next to...

Read the press release
Citryll Announces Appointments of Eduardo Bravo as CEO and Tim Schenk as CBO
29 August 2023

Citryll Announces Appointments of Eduardo Bravo as CEO and Tim Schenk as CBO

Citryll, a clinical-stage biotech company developing first-in-class therapeutics to treat immune-mediated inflammatory diseases, today announced the appointment of Eduardo...

Read more
Alliance Promotion Microbiote applauds the new legislation securing stool collection in France
24 August 2023

Alliance Promotion Microbiote applauds the new legislation securing stool collection in France

The Alliance Promotion Microbiote (APM), a prominent player dedicated to the development, production, and commercialization of therapeutic microbiome-based innovations,...

Read more